110 related articles for article (PubMed ID: 35357497)
1. Retraction of 'MEPE/OF45 protects cells from DNA damage induced killing via stabilizing CHK1'.
Nucleic Acids Res; 2022 Apr; 50(7):4200. PubMed ID: 35357497
[No Abstract] [Full Text] [Related]
2. MEPE/OF45 protects cells from DNA damage induced killing via stabilizing CHK1.
Liu S; Wang H; Wang X; Lu L; Gao N; Rowe PS; Hu B; Wang Y
Nucleic Acids Res; 2009 Dec; 37(22):7447-54. PubMed ID: 19808933
[TBL] [Abstract][Full Text] [Related]
3. A small peptide mimicking the key domain of MEPE/OF45 interacting with CHK1 protects human cells from radiation-induced killing.
Yu X; Wang H; Liu S; Zhang X; Guida P; Hu B; Wang Y
Cell Cycle; 2010 May; 9(10):1981-5. PubMed ID: 20436300
[TBL] [Abstract][Full Text] [Related]
4. MEPE/OF45 as a new target for sensitizing human tumour cells to DNA damage inducers.
Zhang P; Wang H; Rowe PS; Hu B; Wang Y
Br J Cancer; 2010 Mar; 102(5):862-6. PubMed ID: 20145617
[TBL] [Abstract][Full Text] [Related]
5. Regulation of mRNA expression of matrix extracellular phosphoglycoprotein (MEPE)/ osteoblast/osteocyte factor 45 (OF45) by fibroblast growth factor 2 in cultures of rat bone marrow-derived osteoblastic cells.
Zhang GX; Mizuno M; Tsuji K; Tamura M
Endocrine; 2004 Jun; 24(1):15-24. PubMed ID: 15249699
[TBL] [Abstract][Full Text] [Related]
6. MEPE/OF45, a new dentin/bone matrix protein and candidate gene for dentin diseases mapping to chromosome 4q21.
MacDougall M; Simmons D; Gu TT; Dong J
Connect Tissue Res; 2002; 43(2-3):320-30. PubMed ID: 12489176
[TBL] [Abstract][Full Text] [Related]
7. Radiation activated CHK1/MEPE pathway may contribute to microgravity-induced bone density loss.
Zhang X; Wang P; Wang Y
Life Sci Space Res (Amst); 2015 Nov; 7():53-6. PubMed ID: 26553637
[TBL] [Abstract][Full Text] [Related]
8. Targeted disruption of the osteoblast/osteocyte factor 45 gene (OF45) results in increased bone formation and bone mass.
Gowen LC; Petersen DN; Mansolf AL; Qi H; Stock JL; Tkalcevic GT; Simmons HA; Crawford DT; Chidsey-Frink KL; Ke HZ; McNeish JD; Brown TA
J Biol Chem; 2003 Jan; 278(3):1998-2007. PubMed ID: 12421822
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-376a sensitizes cells following DNA damage by downregulating MEPE expression.
Sheng J; Luo W; Yu F; Gao N; Hu B
Cancer Biother Radiopharm; 2013 Sep; 28(7):523-9. PubMed ID: 23570370
[TBL] [Abstract][Full Text] [Related]
10. CHK1 affecting cell radiosensitivity is independent of non-homologous end joining.
Wang H; Hu B; Liu R; Wang Y
Cell Cycle; 2005 Feb; 4(2):300-3. PubMed ID: 15655357
[TBL] [Abstract][Full Text] [Related]
11. Need radioprotection? A MEPE/OF45 mimetic may do the job.
Li CY
Cell Cycle; 2010 Jun; 9(12):2271. PubMed ID: 20581437
[No Abstract] [Full Text] [Related]
12. Ataxin-3 promotes genome integrity by stabilizing Chk1.
Tu Y; Liu H; Zhu X; Shen H; Ma X; Wang F; Huang M; Gong J; Li X; Wang Y; Guo C; Tang TS
Nucleic Acids Res; 2017 May; 45(8):4532-4549. PubMed ID: 28180282
[TBL] [Abstract][Full Text] [Related]
13. PARP and CHK inhibitors interact to cause DNA damage and cell death in mammary carcinoma cells.
Booth L; Cruickshanks N; Ridder T; Dai Y; Grant S; Dent P
Cancer Biol Ther; 2013 May; 14(5):458-65. PubMed ID: 23917378
[TBL] [Abstract][Full Text] [Related]
14. The Mre11 nuclease is critical for the sensitivity of cells to Chk1 inhibition.
Thompson R; Montano R; Eastman A
PLoS One; 2012; 7(8):e44021. PubMed ID: 22937147
[TBL] [Abstract][Full Text] [Related]
15. Chk1-dependent slowing of S-phase progression protects DT40 B-lymphoma cells against killing by the nucleoside analogue 5-fluorouracil.
Robinson HM; Jones R; Walker M; Zachos G; Brown R; Cassidy J; Gillespie DA
Oncogene; 2006 Aug; 25(39):5359-69. PubMed ID: 16619043
[TBL] [Abstract][Full Text] [Related]
16. Interferon-gamma enhances radiation-induced cell death via downregulation of Chk1.
Kim KS; Choi KJ; Bae S
Cancer Biol Ther; 2012 Sep; 13(11):1018-25. PubMed ID: 22825336
[TBL] [Abstract][Full Text] [Related]
17. Increasing cisplatin sensitivity by schedule-dependent inhibition of AKT and Chk1.
Duan L; Perez RE; Hansen M; Gitelis S; Maki CG
Cancer Biol Ther; 2014; 15(12):1600-12. PubMed ID: 25482935
[TBL] [Abstract][Full Text] [Related]
18. In situ localization and in vitro expression of osteoblast/osteocyte factor 45 mRNA during bone cell differentiation.
Igarashi M; Kamiya N; Ito K; Takagi M
Histochem J; 2002 May; 34(5):255-63. PubMed ID: 12588003
[TBL] [Abstract][Full Text] [Related]
19. The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer.
Smith J; Tho LM; Xu N; Gillespie DA
Adv Cancer Res; 2010; 108():73-112. PubMed ID: 21034966
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of autophagy enhances DNA damage-induced apoptosis by disrupting CHK1-dependent S phase arrest.
Liou JS; Wu YC; Yen WY; Tang YS; Kakadiya RB; Su TL; Yih LH
Toxicol Appl Pharmacol; 2014 Aug; 278(3):249-58. PubMed ID: 24823293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
